Bioneutra Global Stock Analysis
| BGACF Stock | USD 0.01 0.00 0.00% |
BioNeutra Global's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. BioNeutra Global's financial risk is the risk to BioNeutra Global stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that BioNeutra Global's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which BioNeutra Global is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of BioNeutra Global to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, BioNeutra Global is said to be less leveraged. If creditors hold a majority of BioNeutra Global's assets, the Company is said to be highly leveraged.
BioNeutra Global is overvalued with Real Value of 0.004704 and Hype Value of 0.0056. The main objective of BioNeutra Global pink sheet analysis is to determine its intrinsic value, which is an estimate of what BioNeutra Global is worth, separate from its market price. There are two main types of BioNeutra Global's stock analysis: fundamental analysis and technical analysis.
The BioNeutra Global pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BioNeutra Global's ongoing operational relationships across important fundamental and technical indicators.
BioNeutra |
BioNeutra Pink Sheet Analysis Notes
About 37.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. BioNeutra Global had not issued any dividends in recent years. BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. Bioneutra Global is traded on OTC Exchange in the United States.The quote for BioNeutra Global is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BioNeutra Global please contact Jianhua Zhu at 780 466 1481 or go to https://www.bioneutra.ca.BioNeutra Global Investment Alerts
| BioNeutra Global generated a negative expected return over the last 90 days | |
| BioNeutra Global has some characteristics of a very speculative penny stock | |
| BioNeutra Global has high likelihood to experience some financial distress in the next 2 years | |
| BioNeutra Global has accumulated 6.34 M in total debt. BioNeutra Global has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BioNeutra Global until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutra Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutra Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutra to invest in growth at high rates of return. When we think about BioNeutra Global's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 15.4 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| About 37.0% of the company shares are held by company insiders |
BioNeutra Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 863.36 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioNeutra Global's market, we take the total number of its shares issued and multiply it by BioNeutra Global's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BioNeutra Profitablity
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.Technical Drivers
BioNeutra Global technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioNeutra Global Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioNeutra Global middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioNeutra Global. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioNeutra Global Debt to Cash Allocation
Many companies such as BioNeutra Global, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
BioNeutra Global has accumulated 6.34 M in total debt. BioNeutra Global has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BioNeutra Global until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutra Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutra Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutra to invest in growth at high rates of return. When we think about BioNeutra Global's use of debt, we should always consider it together with cash and equity.BioNeutra Global Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the BioNeutra Global's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of BioNeutra Global, which in turn will lower the firm's financial flexibility.About BioNeutra Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how BioNeutra Global prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioNeutra shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as BioNeutra Global. By using and applying BioNeutra Pink Sheet analysis, traders can create a robust methodology for identifying BioNeutra entry and exit points for their positions.
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. Bioneutra Global is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding BioNeutra Global to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Complementary Tools for BioNeutra Pink Sheet analysis
When running BioNeutra Global's price analysis, check to measure BioNeutra Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNeutra Global is operating at the current time. Most of BioNeutra Global's value examination focuses on studying past and present price action to predict the probability of BioNeutra Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNeutra Global's price. Additionally, you may evaluate how the addition of BioNeutra Global to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |